Melatonin may fix sleep in diabetic eye disease
NCT ID NCT04547439
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking 3 mg of melatonin each night for 8 weeks can improve sleep and daily body rhythms in people with diabetic retinopathy. Researchers will track sleep patterns and hormone levels in 42 adults aged 40-65 with type 2 diabetes and moderate eye damage. The goal is to see if this simple supplement can ease sleep problems linked to the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Melatonin
- What this could lead to
- If it works, this could point toward a simple, low-cost way to improve sleep and daily rhythms for people with diabetic retinopathy.
- What could go wrong
- This is a small, early-phase trial with only 42 participants. Melatonin may not improve sleep or eye health, and results may not apply to everyone with diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- FitBit coaching may help amputees walk more after surgery
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?